TibaRay
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
47633 Westinghouse Dr, Fremont, Californ...Website
www.tibaray.comRevenue
<$5 MillionIndustry
About TibaRay
TibaRay is focused on revolutionizing cancer treatment through its innovative FLASH radiotherapy technology, which offers faster, more precise, and accessible treatment options. Their breakthrough linear accelerator platform enables rapid treatment delivery, minimizing collateral damage to healthy tissues while maximizing tumor targeting accuracy. The company serves various markets, including healthcare, non-destructive testing, and border security, showcasing the versatility of their technology. With a world-leading team and strong partnerships, TibaRay aims to make curative cancer care available to patients globally.Explore more
TibaRay Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to TibaRay
Compare insights from companies similar to TibaRay, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
TibaRay Tech Stack
A closer look at the technologies used by TibaRay
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TibaRay
Sign Up For FreeTo access detailed company insights
TibaRay is focused on revolutionizing cancer treatment through its innovative FLASH radiotherapy technology, which offers faster, more precise, and accessible treatment options. Their breakthrough linear accelerator platform enables rapid treatment delivery, minimizing collateral damage to healthy tissues while maximizing tumor targeting accuracy.... Read More
